Maintenance therapy (MT) with 25 versus 5 mg lenalidomide (Len) after prolonged Len consolidation therapy (CT) in newly-diagnosed, transplant-eligible patients (pts) with multiple myeloma (MM).

Media type: E-Article
Title: Maintenance therapy (MT) with 25 versus 5 mg lenalidomide (Len) after prolonged Len consolidation therapy (CT) in newly-diagnosed, transplant-eligible patients (pts) with multiple myeloma (MM)
Contributor: Fenk, Roland; Giagounidis, Aristoteles; Goldschmidt, Hartmut; Heinsch, Markus; Rummel, Mathias J.; Kröger, Nicolaus; Boquoi, Amelie; Lopez, David; Hauck, Katarzyna; Gerrlich, Celina; Baier, Julia; Liesenjohann, Svenja; Boelke, Edwin; Mai, Elias; Aul, Carlo; Strapatsas, Judith; Dienst, Ariane; Kondakci, Mustafa; Haas, Rainer; Kobbe, Guido
Published: American Society of Clinical Oncology (ASCO), 2018
Published in: Journal of Clinical Oncology, 36 (2018) 15_suppl, Seite 8016-8016
Language: English
DOI: 10.1200/jco.2018.36.15_suppl.8016
ISSN: 0732-183X; 1527-7755
Origination:
Footnote:
Access State: Open Access

Search in field: